Germany – Pharmaceuticals – Pharmaceutical rebate agreements pursuant to § 130a (8) SGB V within the framework of open-house procedures
Deutschland – Arzneimittel – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren
Germany · Dresden
What the buyer is looking for
Agalsidase beta; ATC-Code: A16AB04
Description as published (DE).
Contract
BuyerIKK classic
TypeSupplies
Estimated valuevalue not published
Published31 January 2025
CategoryMedical equipment & pharma · CPV 33600000
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Abacus Medicine A/S · Kopenhagen | 59 | 2015–2026 |
| EurimPharm Arzneimittel GmbH · Saaldorf-Surheim | 50 | 2016–2026 |
| CC Pharma GmbH · Densborn | 42 | 2012–2023 |
| kohlpharma GmbH · Merzig | 40 | 2014–2023 |
| Aliud Pharma GmbH · Laichingen | 36 | 2011–2023 |
From 13.7M documented awards · regular winners know this buyer's requirements — that is your competition.
How often this buyer tenders this
2019201
2020186
2021162
2022163
2023154
2024116
20251
2025196
202691
Who knows the rhythm prepares instead of reacting.
138
days until the deadline — Tuesday 5 January at 00:00
How to bid
Read the full notice — Original + documents
Goes directly to this tender on TED — Tenders Electronic Daily. The full specification and all annexes are there.
Tenders like this, every morning at 7:30 in your inbox.
Start free →